ANDREW YEE to B-Cell Maturation Antigen
This is a "connection" page, showing publications ANDREW YEE has written about B-Cell Maturation Antigen.
Connection Strength
0.230
-
Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma. Leuk Lymphoma. 2024 Dec; 65(12):1789-1800.
Score: 0.230
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.